Best Brachytherapy for prostate cancer doctors: TOP 25 doctors

Dr. Mustafa Solak is a medical oncologist with expertise in breast, testicular, ovarian, lung, head-neck, and gastrointestinal cancers. He graduated from Hacettepe University School of Medicine. He completed his residency at Istanbul Sisli Etfal Teaching and Research Hospital. He then pursued a fellowship at Hacettepe University Cancer Institute.

Dr. Solak has managed many complex cancer cases. He has contributed to clinical advancements at respected centers, including the University of Texas MD Anderson Cancer Center. He has also worked at Hitit University Corum Training Hospital and Medical Park Hospital. His experience shows a strong commitment to cancer care and research.

Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).

Specialty:

• Treatment of all types of lung cancer and thoracic organs
• Treatment of all types of sarcomas of bone and soft tissue
• Treatment stromal tumors of the gastrointestinal tract

Education and specialization:

• Higher medical education, graduated the Medical Faculty of the Hebrew University of Jerusalem, Israel
• Residency in General Oncology and Radiotherapy
• Training in the field of radiotherapy and brachytherapy at New York Hospital, USA
• Special refresher course for the treatment of tumors of the skeleton and soft tissues, Paris. France

Membership:

• President of the Society of oncologists and radiotherapists Israel
• The American Scientific Cancer Society
• European scientific medical organization
• European Society of Oncology of the musculoskeletal system
• International Society for the treatment of tumors of the connective tissue

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.

Education

09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, Germany, Doctoral thesis, grade: summa cum laude

05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg

01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology

03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany

07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus

Professional Career

09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director

Professional Memberships and Distinctions

2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

2021           Best Abstract, EMUC congress 2021, Athens, Greece

2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

2023           Invited member of the ESTRO focus group “Urology”

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Education/Residency:

• Completed residency in general oncology and radiotherapy (radiation therapy) at Sheba Hospital, Tel Hashomer.
• During her work, she gained extensive experience in treating tumors of the female reproductive system and is currently a coordinator for the treatment of patients suffering from these diseases.
• Fellowship - Anderson Cancer Center, Houston, Texas - 2012-2014

Dr. Tatyana Rabin's research interests include:

Methods of destruction of malignant neoplasms by heating with the help of ultrasonic waves, research into the use of brachytherapy in the treatment of oncogynecological diseases,

study of the mechanisms of response at the molecular level of prostate tumor cells to radiotherapy;

clinical studies of oncomammology, oncopulmonology, ocular lymphoma.

Dr. Rabin is investigating the molecular mechanisms by which prostate cancer cells respond to radiation therapy. This research is being conducted in collaboration with the Weizmann Institute of Science.

In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.

Dr. Rabin is currently coordinating a new and unique study at Sheba Hospital that is investigating a method of treating cancerous tumors using MRI-guided ultrasound waves. This method involves raising the tumor's temperature to a certain level and then destroying it.

Awards:

Dr. Tatyana Rabin was recognized as the best hospital employee for 2007.

Experience and participation in scientific research:

• Scientific research in the field of gynecological oncology
• Scientific research in the field of lung tumors
• Application of brachytherapy in oncogynecology
• SBRT techniques in the treatment of tumors of the respiratory system
• Study of molecular mechanisms of prostate tumor cell response to radiation therapy. This study was organized in collaboration with the laboratory of the H. Weizmann Institute.
• In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.

Membership in medical societies :

• Israel Society of Oncology and Clinical Radiotherapy (ISCORT) American Society of Radiology and Oncology (ASTRO)
• Israel Association of Palliative Medicine

Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.

She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.

Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Education

• (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
• (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

• (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye

Prof. Mark Schrader is a German urologist with 25 years of experience, specializing in treatment of urological tumors and minimally invasive surgeries for kidney, bladder, and prostate formations. He holds a degree in general medicine, specialties in cardiovascular surgery, general surgery, and urology, and is a member of the Berlin Medical Association and The German Society for Ultrasound in Medicine.

Dr. Raj Nagarkar is a leading Surgical Oncologist with 19 years of experience. He has performed over 50,000 cancer surgeries. His main focus areas are Breast and Thoracic Surgical Oncology. He is involved in more than 200 clinical trials and has contributed to many national and international publications.

Dr. Nagarkar trained in Surgical Oncology at Tata Memorial Hospital, Mumbai. He also holds an MRCS from the Royal College of Surgeons, Edinburgh. He teaches DNB Superspecialty Surgical Oncology and Breast Surgery at Maharashtra University of Health Sciences. Dr. Nagarkar is dedicated to improving the quality of life for his patients.

Areas of Interest

• Breast Cancer
• Prostate Cancer
• Gastrointestinal System Tumors
• Gynecological Tumors
• Brain Tumors
• Lung Cancer

Education
2021:

• Professor Title, Health Sciences University Hamidiye Faculty of Medicine

2017 – 2018:

• Master's Degree in Phytotherapy, Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University

2015:

• Associate Professor Title

1996:

• Radiation Oncology Specialization, Princess Margaret Hospital, Toronto, Canada

1994 – 1998:

• Radiation Oncology Specialization, Şişli Etfal Training and Research Hospital

1982 – 1988:

• Trakya University Faculty of Medicine

Work Experience
2024:

• Neolife Medical Center – Biruni University

2021 – 2024:

• Health Sciences University (Hamidiye Faculty of Medicine – Bursa Medical Faculty – Izmir Medical Faculty – Lecturer)

2020 – 2024:

• SBÜ Başakşehir Çam and Sakura City Hospital – Education and Administrative Officer

2015 – 2020:

• Dr. Sadi Konuk Training and Research Hospital – Radiation Oncology Clinical Department Setup and Administrative Officer

2013 – 2020:

• Gelişim University – Lecturer, Radiation Therapy Technician Program

2009 – 2015:

• Istanbul Training and Research Hospital, Radiation Oncology Center Setup, Clinical Administrative Responsibility, and Chief Assistant

1998 – 2009:

• Şişli Etfal Training and Research Hospital, Radiation Oncology Clinic Chief Assistant

Professional Trainings
2023:

• Project Creation and Development on Artificial Intelligence and Radiotherapy Treatment Planning Systems with Yıldız Technical University

2023:

• Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2015:

• Turkish Radiation Oncology Association (Mammography Working Group, Integrative Working Group, Stereotactic Working Group, Uro-Oncology Working Group), Researcher

2020:

• Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2018:

• Distance Good Clinical Practices Training; Basic Good Clinical Practices Course

2011:

• Lifelong Learning Program Leonardo da Vinci Mobility Projects, European Union Education and Youth Programs Directorate

2008:

• Brachytherapy Training, Istanbul University, Oncology Institute

Memberships
2022 – 2024:

• President of Sakura Science and Academician Association (SABADER)

2023:

• Turkish Radiation Oncology Association, Integrative Working Group Executive Board Member

2021:

• Cam & Sakura Medical Journal, Section Editor

2018:

• Interdisciplinary Oncology Association, Substitute Member of the Executive Board

1995:

• Turkish Radiation Oncology Association

1989:

• Turkish Medical Association

Scientific Works

• A.1 Karacetin D, Yalcin B, Okten B, Oztürk S, Maral O, Incekara O (2009). Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer. JBUON, 605-608
• A.2 Yılmaz O B, Karacetin D, Kabukcuoglu F, Taskin T, Yener S (2011). Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas. Pol J Pathol, 62(1), 19-24
• A.3 Karacetin D, Cakir A, Agaoglu F, Çamlıca H, Ergen A, Dizdar Y, Darendeliler E (2010). Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of femur doses for four treatment techniques. Journal of Radiotherapy in Practice, 41-51
• A.4 Baycan D, Karacetin D, Balkanay A, Barut Y (2012). Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison. Jpn J Radiol, DOI: 10.1007/s

Education:

• 2008 – 2012: Marmara University School of Medicine (Specialization Training)
• 1998 – 2005: Istanbul University Cerrahpaşa School of Medicine

Work Experience:

• 2012 – Present: Neolife Medical Center

Memberships:

• Turkish Society of Radiation Oncology

Scientific Works:

2014:

• 11th National Radiation Oncology Congress
  • Oral Presentation: "Late-stage kidney damage after chemoradiotherapy in gastric cancer patients, clinical, functional, and dosimetric examination of tolerance doses."
  • Poster Presentation: "Early-stage stereotactic radiotherapy results in lung metastases."

2011:

• 1st Evidence-Based Medicine Course
  • "Evaluation of late side effects in patients treated with conformal radiotherapy for localized prostate cancer: A TOG Side Effects Subgroup Study."

Dr. Ahmer Arif Shaikh, MDS (Oral & Maxillofacial Surgery), is a specialist in Surgical Oncology. He has 3 years of experience at HCG Manavata Cancer Centre, Nashik. He focuses on oral cancer treatment, organ preservation, and functional rehabilitation for oral cancer patients.

Dr. Shaikh has completed a Fellowship in Head & Neck Surgical Oncology. He is skilled in complex maxillofacial and head & neck surgeries. He is also an active researcher with several publications in reputed journals. His work shows a strong commitment to improving cancer care.

Dr. Lalit Banswal is an experienced oncological surgeon with 10 years in the field. He has performed more than 10,000 major surgeries. He earned his MBBS from MIMER, Pune, and completed his MS at GMC Panaji. He also completed a fellowship in Surgical Oncology at Tata Medical Centre, Kolkata, with a focus on gastrointestinal cancers.

Dr. Banswal has worked as a Co-principal Investigator in several research projects. He has published his work in both national and international journals. He is known for his patient-friendly and ethical approach. His main expertise is in Minimal Invasive Cancer Surgeries, where he consistently delivers excellent results.

Dr. Shaunak Valame is an MD in Internal Medicine and holds a DNB in Medical Oncology. He received advanced training at Indraprastha Apollo Hospital in New Delhi. He also worked as a Registrar at Jawaharlal Nehru Cancer Hospital in Bhopal. Dr. Valame has presented his research at international forums, including the Gastrointestinal Cancer Symposium in San Francisco.

He is known for his work in targeted cancer therapies. He has given lectures at the International Winter School of Oncology at AIIMS Bhopal. Dr. Valame is accredited by the American Society of Clinical Oncology. He is committed to advancing cancer research and clinical care.

Dr. Shruti Kate is an experienced oncologist. She specializes in treating lung, breast, gynecological, and genitourinary cancers. She earned her MBBS from Lady Hardinge Medical College. She completed her MD in Internal Medicine at Maulana Azad Medical College. She also holds a DM in Medical Oncology from Tata Memorial Hospital, Mumbai.

Dr. Kate has managed both conservative and surgical cancer treatments. She is skilled in complex procedures such as the Whipple surgery. She is a member of several leading oncology societies, including ASCO, ESMO, IASCLC, ISMPO, and IOS. Her research on lung cancer received the only travel award from India at the 2018 World Conference on Lung Cancer.